HOME / Featured News / FEDERAL HEALTH REFORM NEWS
Feds Don't Exempt Texas From Health Reform 80% Rule
Rate This Article:
0
Dallasnews.com REPORTS HERE that "the federal government on Friday refused to let Texas ease a requirement that health insurers devote at least 80 percent of premium revenue to medical care."

"The new federal rule, which makes insurers falling short of the mark pay back the difference to consumers, will bring rebate checks on last year's premiums to thousands of Texans as early as August."

"Officials of the U.S. Department of Health and Human Services said Texas insurance regulators did not convincingly back up their claim that immediate enforcement of the medical-spending minimums would disrupt the state's "individual market." That's where about 750,000 Texans buy policies without any help from their employers."

Federal officials considered Texas' arguments and data, but said in a letter to state Insurance Commissioner Elizabeth Kitzman, "We conclude that the evidence presented does not establish a reasonable likelihood" the market will be destabilized.

"Last summer, the state Department of Insurance sought relief. It said requiring an 80-percent "medical loss ratio" – where insurers have to devote at least that much of premium dollars to medical care, or give back the difference -- was too drastic a change."

"Companies would flee and that would 'result in fewer choices for consumers,' argued former Commissioner Mike Geeslin, who was Kitzman's predecessor and -- like her, an appointee of Gov. Rick Perry."

"Geeslin applied for permission to let Texas insurers devote just 71 percent of individuals' premiums to care and quality improvements this year, 74 percent next year and 77 percent in 2013. In 2014, all state-regulated policies will have to meet the federally set marks."

"Federal officials, however, noted Friday that insurers covering at least 93 percent of the Texans covered by individual policies have said they won't leave the market or are at or close to the minimum-spending goal already."

"The rule is a key provision of the federal health care overhaul and is changing insurers' behavior, and not just in the individual market, said Gary Cohen, a federal official who oversees health insurance, told reporters."

"Although adjustments are allowed only for a state's individual market, the broader rule could benefit several million other Texans, whose employers do not self-insure but instead purchase policies regulated by the state. State officials have said they don't have reliable numbers but consumer groups say as many as five million people are in the state-regulated health insurance markets."

"To avoid rebates, insurers must spend at least 80 percent on medical care and quality improvements in the markets for individuals and small groups – 2 to 50 employees; and at least 85 percent in the large group market."

"Seventeen states sought adjustments to the rule in their individual markets.  Of them, six states have been granted full or partial relief, Cohen said. Nine more, including Texas, were denied. Decisions on Wisconsin and North Carolina are pending, he said."

 
Post A Comment
* Indicates Required Field
Comment Title:
* Comments:
Nickname:
* Validation:
Most Recent Comments
 
 
FeaturedNews
Clinical Trial Data Should Be Open for Review
Published 04/30/2012 - 3:14 p.m.  CDT

Original clinical study reports, which contain far more detail than published randomized trials, should be made available to independent researchers seeking to verify efficacy and safety claims.

In support of this argument, the history of the influenza antiviral oseltamivir (Tamiflu), which was approved by the FDA in 1999, was cited. The widespread belief in oseltamivir's efficacy, was based on a meta-analysis of 10 trials conducted by the manufacturer prior to licensure.  But the authors pointed out that the FDA, which was aware of these clinical trials, concluded that oseltamivir had not been shown to reduce complications and required a statement on the drug's label to that effect.  Moreover, oseltamivir was not given an FDA indication for prevention of spread of influenza.

To this, [authors] commented, "If FDA is right, the drug's effectiveness may be no better than aspirin or acetaminophen.'"
...Read More
HR 329 in need of Co Sponsors
Published 04/30/2012 - 11:11 a.m.  CDT

Representative Bob Filner recently introduced the Chiropractic Care to All Veterans Act (H.R. 329). The bill would require the Veterans Administration (VA) to have a chiropractic physician on staff at all major VA medical facilities by 2014. You too can help ensure chiropractic care is available to those who have placed their lives in service to our country. H.R. 329 is in need of cosponsors to assist its likelihood of passage.

CLICK HERE to urge your legislators to cosponsor the bill.
...Read More
Court Sides with Generic-Drug Makers
Published 04/25/2012 - 6:33 a.m.  CDT

In a unanimous decision, the Supreme Court ruled that generic drugmaker Caraco Pharmaceutical Laboratories can sue Novo Nordisk for what Caraco says are exaggerated descriptions of the scope of patents Novo Nordisk holds on a diabetes drug.

A group of Democratic senators has introduced a bill that would allow people to sue generic drugmakers over failing to update their drug labels to include all known risks. The bill is meant to counter last year's Supreme Court decision in a generic drug dispute.
...Read More
Reader Login
Username:
Password:
 Save Login?
Free Sign-up
Forgot Password?
Reader Control Panel

The TCA Web sites will be under going change in the next few weeks.  Please bear with us while we complete some improvements.

Original clinical study reports, which contain far more detail than published randomized trials, should be made available to independent researchers seeking to verify efficacy and safety claims.

In support of this argument, the history of the influenza antiviral oseltamivir (Tamiflu), which was approved by the FDA in 1999, was cited. The widespread belief in oseltamivir's efficacy, was based on a meta-analysis of 10 trials conducted by the manufacturer prior to licensure.  But the authors pointed out that the FDA, which was aware of these clinical trials, concluded that oseltamivir had not been shown to reduce complications and required a statement on the drug's label to that effect.  Moreover, oseltamivir was not given an FDA indication for prevention of spread of influenza.

To this, [authors] commented, "If FDA is right, the drug's effectiveness may be no better than aspirin or acetaminophen.'"

The Kilgore College Small Business Development Center (SBDC) will sponsor an educational seminar for medical office staff, including office managers and billing staff, entitled Basic Workers’ Compensation for Medical Office Staff on Wednesday, May 2, 2012.

Representative Bob Filner recently introduced the Chiropractic Care to All Veterans Act (H.R. 329). The bill would require the Veterans Administration (VA) to have a chiropractic physician on staff at all major VA medical facilities by 2014. You too can help ensure chiropractic care is available to those who have placed their lives in service to our country. H.R. 329 is in need of cosponsors to assist its likelihood of passage.

CLICK HERE to urge your legislators to cosponsor the bill.

An $8 billion Medicare demonstration program is poorly designed and should be cancelled, the nonpartisan Government Accountability Office (GAO) said. The program is designed to reward the highest-quality Medicare Advantage plans, but instead pays out most of its award money to mediocre plans, according to a report.


Ethiopia and Kenya Trips.  Have you ever wanted to provide chiropractic care in another country and give back to those in need?

Dr. Teresa Jones has been volunteering on mission trips to Africa for 4 years and is reaching out to the District 5 for help this year. There are two chances to participate, both in July 2012 and if you are interested please RSVP to frontdesk@wholehealth-care.com to let her know you area interested!


The Patient-Centered Outcomes Research Initiative (PCORI), established by the 2010 Patient Protection and Affordable Care Act, has set five priorities as the group's research agenda for the coming years, with the overall goal of advancing clinical effectiveness research. …. the priorities [are] as follows...

Girls who face multiple social stressors at home as toddlers are more likely to be obese by age 5, researchers found.

Nonpharmacologic pain management appears to be safe for mother and baby, although there is limited published evidence to explain its efficacy, according to a Cochrane Review.

There is more data to support the ef?cacy of pharmacologic pain management, such as epidurals and opioids, but these methods lead to more adverse effects.  This reports reports upon some of these
Regulators on both sides of the Atlantic were slow to inform patients and their doctors about problems with metal-on-metal hip implants and relied on industry officials and consultants in crafting their responses.

Complications included high failure rates and possible systemic effects from elevated metal ion levels in the blood.  An advisory has been issued to surgeons, telling them that patients who have received metal-on-metal implants should have annual checkups for life. The evaluations should include testing for metal ions in the blood as well as for clinical symptoms of device failure.